{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:33:30Z","timestamp":1785890010594,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":636,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["R00HL119605"],"award-info":[{"award-number":["R00HL119605"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007588","name":"WSU College of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1074\/jbc.ra118.004673","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:50:24Z","timestamp":1540529424000},"page":"19672-19685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy"],"prefix":"10.1016","volume":"293","author":[{"given":"Peng","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuening","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9646-4824","authenticated-orcid":false,"given":"Zhaokang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.004673_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin"},{"key":"10.1074\/jbc.RA118.004673_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA118.004673_bib3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA118.004673_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2921","article-title":"Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin","volume":"4","author":"Pang","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA118.004673_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA118.004673_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9583268","article-title":"Signaling pathways in cardiac myocyte apoptosis","volume":"2016","author":"Xia","year":"2016","journal-title":"Biomed. Res. Int"},{"key":"10.1074\/jbc.RA118.004673_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2013.12.002","article-title":"Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.)","volume":"67","author":"Cheng","year":"2014","journal-title":"J Mol. Cell Cardiol"},{"key":"10.1074\/jbc.RA118.004673_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.RA118.004673_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol"},{"key":"10.1074\/jbc.RA118.004673_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.004673_bib11","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA118.004673_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/onc.2009.340","article-title":"DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2","volume":"29","author":"Bourke","year":"2010","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA118.004673_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/en.2009-1116","article-title":"Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition","volume":"151","author":"Flores","year":"2010","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.RA118.004673_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCULATIONAHA.113.002203","article-title":"An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential","volume":"128","author":"Jay","year":"2013","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA118.004673_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0896-6273(04)00017-0","article-title":"Cell cycle activation linked to neuronal cell death initiated by DNA damage","volume":"41","author":"Kruman","year":"2004","journal-title":"Neuron"},{"key":"10.1074\/jbc.RA118.004673_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(25)09073-X","article-title":"Cell cycle-dependent cytotoxicity, G2\/M phase arrest, and disruption of p34cdc2\/cyclin B1 activity induced by doxorubicin in synchronized P388 cells","volume":"49","author":"Ling","year":"1996","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.RA118.004673_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1158\/1535-7163.MCT-15-0519","article-title":"Sequential combination therapy of CDK inhibition and doxorubicin is synthetically lethal in p53-mutant triple-negative breast cancer","volume":"15","author":"Jabbour-Leung","year":"2016","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.RA118.004673_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20101547","article-title":"miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes","volume":"208","author":"Qian","year":"2011","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA118.004673_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"Sarosiek","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA118.004673_bib20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1073\/pnas.1214608110","article-title":"Cardiomyocyte proliferation contributes to heart growth in young humans","volume":"110","author":"Mollova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.004673_bib21","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.004673_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.RES.88.4.443","article-title":"Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes","volume":"88","author":"Liao","year":"2001","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA118.004673_bib23","doi-asserted-by":"crossref","first-page":"35858","DOI":"10.1074\/jbc.M404975200","article-title":"Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium","volume":"279","author":"Chaudhry","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.004673_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007668","article-title":"Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.RA118.004673_bib25","doi-asserted-by":"crossref","first-page":"52630","DOI":"10.1074\/jbc.M402037200","article-title":"Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure","volume":"279","author":"Sarkar","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.004673_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.RES.88.4.408","article-title":"Cyclin A\/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes","volume":"88","author":"Adachi","year":"2001","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA118.004673_bib27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000041030.98642.41","article-title":"Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes","volume":"91","author":"Hauck","year":"2002","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA118.004673_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.yjmcc.2008.07.003","article-title":"Cyclin-dependent kinase 2 signaling regulates myocardial ischemia\/reperfusion injury","volume":"45","author":"Liem","year":"2008","journal-title":"J. Mol. Cell Cardiol"},{"key":"10.1074\/jbc.RA118.004673_bib29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.20172246","article-title":"CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss","volume":"215","author":"Teitz","year":"2018","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA118.004673_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/104454901750361479","article-title":"The long form of CDK2 arises via alternative splicing and forms an active protein kinase with cyclins A and E","volume":"20","author":"Ellenrieder","year":"2001","journal-title":"DNA Cell Biol"},{"key":"10.1074\/jbc.RA118.004673_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ydbio.2014.04.018","article-title":"Phosphorylation of CDK2 at threonine 160 regulates meiotic pachytene and diplotene progression in mice","volume":"392","author":"Liu","year":"2014","journal-title":"Dev. Biol"},{"key":"10.1074\/jbc.RA118.004673_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1083\/jcb.148.1.59","article-title":"Caspase-dependent Cdk activity is a requisite effector of apoptotic death events","volume":"148","author":"Harvey","year":"2000","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.RA118.004673_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200303026","article-title":"FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons","volume":"162","author":"Gilley","year":"2003","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.RA118.004673_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.1130512","article-title":"CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage","volume":"314","author":"Huang","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.004673_bib35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1190217","article-title":"BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program","volume":"330","author":"Ren","year":"2010","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.004673_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.167","article-title":"Bax\/Bak activation in the absence of Bid, Bim, Puma, and p53","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.RA118.004673_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166233","article-title":"Targeting CDKs with roscovitine increases sensitivity to DNA damaging drugs of human osteosarcoma cells","volume":"11","author":"Vella","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA118.004673_bib38","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1158\/0008-5472.CAN-08-1333","article-title":"Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model","volume":"68","author":"Lambert","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA118.004673_bib39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2005-01-0320","article-title":"Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma","volume":"106","author":"Raje","year":"2005","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.004673_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ijc.23938","article-title":"Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model","volume":"124","author":"Appleyard","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.RA118.004673_bib41","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1158\/1078-0432.CCR-11-3203","article-title":"The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial","volume":"18","author":"Luke","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.RA118.004673_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-13-29","article-title":"Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276\u201300 in human non-small cell lung cancer cells","volume":"13","author":"Rathos","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.RA118.004673_bib43","article-title":"Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820310978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820310978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.004673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:55:52Z","timestamp":1775253352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820310978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0021925820310978"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.004673","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.004673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Xia et al.","name":"copyright","label":"Copyright"}]}}